Details for New Drug Application (NDA): 090526
✉ Email this page to a colleague
The generic ingredient in OXYBUTYNIN is oxybutynin chloride. There are sixteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the oxybutynin chloride profile page.
Summary for 090526
Tradename: | OXYBUTYNIN |
Applicant: | Barr Labs Div Teva |
Ingredient: | oxybutynin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 3.9MG/24HR | ||||
Approval Date: | Mar 4, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription